CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 40 filers reported holding CONMED CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $4,878,000 | +4.0% | 3,000,000 | 0.0% | 1.90% | -37.5% |
Q1 2021 | $4,690,000 | +18.5% | 3,000,000 | +5.6% | 3.05% | -24.3% |
Q4 2020 | $3,958,000 | +24.3% | 2,840,000 | 0.0% | 4.02% | +0.7% |
Q3 2020 | $3,184,000 | +51.9% | 2,840,000 | +42.0% | 3.99% | +5.5% |
Q2 2020 | $2,096,000 | +45.7% | 2,000,000 | +29.8% | 3.79% | +83.3% |
Q1 2020 | $1,439,000 | – | 1,541,000 | – | 2.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABSOLUTE INVESTMENT ADVISERS, LLC | 4,115,000 | $4,708,428 | 0.71% |
ZAZOVE ASSOCIATES LLC | 5,455,000 | $6,306 | 0.58% |
SHENKMAN CAPITAL MANAGEMENT INC | 4,076,000 | $4,644,575 | 0.29% |
MACKAY SHIELDS LLC | 6,287,000 | $7,123,996 | 0.18% |
CAPSTONE INVESTMENT ADVISORS, LLC | 15,994,000 | $18,201,172 | 0.13% |
WOLVERINE ASSET MANAGEMENT LLC | 8,997,000 | $10,397,505 | 0.11% |
Teton Advisors, Inc. | 350,000 | $404,604 | 0.10% |
PALISADE CAPITAL MANAGEMENT, LP | 3,264,000 | $3,759,802 | 0.10% |
Calamos Wealth Management LLC | 384,000 | $436,992 | 0.03% |
GABELLI FUNDS LLC | 3,000,000 | $3,468,030 | 0.03% |